Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Klotho Is a Neuroprotective and Cognition-Enhancing Protein.
Progressive Multifocal Leukoencephalopathy: Why Gray and White Matter.
Flupirtine: pharmacology and clinical applications of a nonopioid analgesic and potentially neuroprotective compound.
Transdermal Application of Myelin Peptides in Multiple Sclerosis Treatment.
Randomized controlled trial of interferon- beta-1a in secondary progressive MS: Clinical results.
Neuronal expression of pathological tau accelerates oligodendrocyte progenitor cell differentiation.
Combination therapy of interferon Beta-1b and tacrolimus: a pilot safety study.
Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. European Study Group on interferon beta-1b in secondary progressive MS.
Berlex continues legal challenge to FDA over MS drug.
Interferon-beta stabilizes barrier characteristics of the blood-brain barrier in four different species in vitro.
HLA alleles as biomarkers of high-titre neutralising antibodies to interferon-β therapy in multiple sclerosis.
Clinical and MRI predictors of response to interferon-beta and glatiramer acetate in relapsing-remitting multiple sclerosis patients.
CCR2 defines in vivo development and homing of IL-23-driven GM-CSF-producing Th17 cells.
The effects of teriflunomide on lymphocyte subpopulations in human peripheral blood mononuclear cells in vitro.
IL-17 and GM-CSF Expression Are Antagonistically Regulated by Human T Helper Cells.
Attenuation of 7-ketocholesterol-induced overproduction of reactive oxygen species, apoptosis, and autophagy by dimethyl fumarate on 158N murine oligodendrocytes.
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.
Visualizing Non-Gaussian Diffusion: Clinical Application of q-Space Imaging and Diffusional Kurtosis Imaging of the Brain and Spine.
Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report.
Information for healthcare professionals: Rituximab
Clinical and radiologic rebound after discontinuation of natalizumab therapy in a highly active multiple sclerosis patient was not halted by dimethyl-fumarate: a case report.
Flupirtine shows functional NMDA receptor antagonism by enhancing Mg2+ block via activation of voltage independent potassium channels. Rapid communication.
Flupirtine
NF-κB transcriptional activation by TNFα requires phospholipase C, extracellular signal-regulated kinase 2 and poly(ADP-ribose) polymerase-1.
Clinical utility of the list sign as a predictor of non-demyelinating disorders in a multiple sclerosis (MS) practice.

Pages